Search
Patexia Research
Case number 1:18-cv-00924

Mesa Digital LLC v. Sony Mobile Communications (USA) Inc. > Summary

Court Case Number 1:18-cv-00924

Filing Date Feb 5, 2018

Termination Date Jun 22, 2018

Court Illinois Northern District Court

Status Dismissed - Voluntarily

Appeal2019-2156

JudgesEdmond E. Chang

Plaintiff

Mesa Digital LLC

Defendant

Sony Group Corporation

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
09868760 Protein purification Jan 16, 2018
09714293 Production of proteins in glutamine-free cell culture media Jul 25, 2017
09646444 Electronic wireless hand held multimedia device May 9, 2017
09493744 Methods for viral inactivation and other adventitious agents Nov 15, 2016
09487809 Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase Nov 8, 2016
09428766 Protein expression from multiple nucleic acids Aug 30, 2016
09249218 Protein purification Feb 2, 2016
09080183 Promoter Jul 14, 2015
09047438 Chromatography equipment characterization Jun 2, 2015
09031537 Electronic wireless hand held multimedia device May 12, 2015
08771988 Protein expression from multiple nucleic acids Jul 8, 2014
08710196 Protein purification Apr 29, 2014
08691232 Extending time to disease progression or survival in cancer patients Apr 8, 2014
08574869 Prevention of disulfide bond reduction during recombinant production of polypeptides Nov 5, 2013
08512983 Production of proteins in glutamine-free cell culture media Aug 20, 2013
08460895 Method for producing recombinant proteins with a constant content of pCO2 in the medium Jun 11, 2013
08440402 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy May 14, 2013
08425908 Treatment with anti-ErbB2 antibodies Apr 23, 2013
08357301 Chromatography equipment characterization Jan 22, 2013
08314225 Heavy chain mutant leading to improved immunoglobulin production Nov 20, 2012
08076066 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy Dec 13, 2011
08044017 Protein purification Oct 25, 2011
07993834 Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy Aug 9, 2011
07923221 Methods of making antibody heavy and light chains having specificity for a desired antigen Apr 12, 2011
07892549 Treatment with anti-ErbB2 antibodies Feb 22, 2011
07846441 Treatment with anti-ErbB2 antibodies Dec 7, 2010
07501122 Treatment with anti-ErbB2 antibody combinations Mar 10, 2009
07449184 Fixed dosing of HER antibodies Nov 11, 2008
07371379 Dosages for treatment with anti-ErbB2 antibodies May 13, 2008
06870034 Protein purification Mar 22, 2005
06627196 Dosages for treatment with anti-ErbB2 antibodies Sep 30, 2003
06620918 Separation of polypeptide monomers Sep 16, 2003
06586206 Methods for making recombinant proteins using apoptosis inhibitors Jul 1, 2003
06489447 Protein purification Dec 3, 2002
06417335 Protein purification Jul 9, 2002
06407213 Method for making humanized antibodies Jun 18, 2002
06331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein Dec 18, 2001
06242177 Methods and compositions for secretion of heterologous polypeptides Jun 5, 2001
06121428 Protein recovery Sep 19, 2000
Menu